Holen Sie sich die Stockscreener-App
1.10
5.98%
-0.07
Schlusskurs vom Vortag:
$1.17
Offen:
$1.22
24-Stunden-Volumen:
66,904
Relative Volume:
0.39
Marktkapitalisierung:
$28.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-3,000
KGV:
0.2181
EPS:
5.0425
Netto-Cashflow:
$-13.22M
1W Leistung:
+3.77%
1M Leistung:
+10.00%
6M Leistung:
+41.03%
1J Leistung:
+83.03%
1-Tages-Spanne:
$1.05
$1.22
1-Wochen-Bereich:
$1.01
$1.22
52-Wochen-Spanne:
$0.375
$1.45
AEON Biopharma Inc. Stock (AEON) Company Profile
Firmenname
AEON Biopharma Inc.
Sektor
Branche
Telefon
(949) 354-6499
Adresse
5 Park Plaza, Suite 1750, Irvine
Compare AEON vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
1.12 | 29.60M | 0 | -3,000 | -13.22M | 5.0425 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.61 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
744.65 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
701.07 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.58 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
283.40 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-08-18 | Eingeleitet | H.C. Wainwright | Buy |
AEON Biopharma Inc. Aktie (AEON) Neueste Nachrichten
AEON Biopharma names John Bencich as chief financial officer - Investing.com Australia
AEON Biopharma Strengthens Finance Leadership with New CFO - TipRanks
AEON Biopharma names John Bencich as chief financial officer By Investing.com - Investing.com Canada
AEON Biopharma Appoints John Bencich as Chief Financial Officer - Bitget
AEON Biopharma, Inc. Appoints John Bencich as Chief Financial Officer, Effective as of March 9, 2026 - marketscreener.com
How cyclical is AEON Biopharma Inc. Class stock compared to rivalsInflation Watch & AI Enhanced Trading Signals - Naître et grandir
AEON (AEON) CLO adds large stock awards and converts prior RSUs - Stock Titan
Botox biosimilar study from AEON Biopharma set for big U.S. neurology meeting - Stock Titan
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting - Bitget
AEON PE Ratio & Valuation, Is AEON Overvalued - Intellectia AI
Breakout Zone: Is AEON Biopharma Inc stock good for income investorsJuly 2025 Action & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
AEON Technical Analysis & ETF Price Forecast - Intellectia AI
Will AEON Biopharma Inc. outperform small cap indexes2025 Sector Review & Real-Time Volume Triggers - mfd.ru
AEON Biopharma (AEON) CEO awarded 3,000,000 restricted stock units - Stock Titan
AEON (AEON) files resale prospectus for up to 51.3M shares - Stock Titan
Guidance Update: Whats the profit margin of AEON Biopharma IncWeekly Market Outlook & AI Driven Price Forecasts - baoquankhu1.vn
Will AEON Biopharma Inc. stock benefit from commodity pricesJuly 2025 Sentiment & Technical Buy Zone Confirmation - mfd.ru
Short Covering: Can AEON Biopharma Inc. weather a recessionWeekly Trading Summary & Weekly Watchlist of Top Performers - baoquankhu1.vn
Profit Review: Is AEON Biopharma Inc in a long term uptrendMarket Sentiment Summary & Daily Stock Trend Reports - baoquankhu1.vn
Midday Stock Roundup: MDxHealth Up 9% Since Preliminary Q4, FY Results - Orange County Business Journal
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions - The Manila Times
AEON Biopharma completes FDA meeting, shareholders approve transactions - Investing.com
Aeon Biopharma stock falls after FDA meeting and debt restructuring By Investing.com - Investing.com Nigeria
Aeon Biopharma stock falls after FDA meeting and debt restructuring - Investing.com
Aeon Biopharma Reports bpd Type 2A Meeting With FDA And Shareholder Approval Of The November Transactions - TradingView
AEON Biopharma completes FDA meeting, shareholders approve transactions By Investing.com - Investing.com Nigeria
Shareholders back AEON debt-cut deals after FDA meeting on Botox biosimilar - Stock Titan
Growth Value: Is AEON Biopharma Inc stock good for income investorsQuarterly Trade Summary & Community Supported Trade Ideas - baoquankhu1.vn
Is EverQuote Inc. stock attractive for passive investorsWeekly Investment Summary & Long-Term Safe Return Strategies - bollywoodhelpline.com
Midday Stock Roundup: loanDepot Jumps on Trump’s Proposed Mortgage Plan - Orange County Business Journal
Rate Cut: Whats the MACD signal for AEON Biopharma Inc2025 Macro Impact & AI Powered Market Entry Ideas - baoquankhu1.vn
Do Not Use - ocbj.com
Market Wrap: Can AEON Biopharma Inc keep up with sector leadersJuly 2025 Rallies & Risk Controlled Swing Alerts - baoquankhu1.vn
AEON Biopharma (AEON) Price Target Decreased by 14.75% to 5.30 - Nasdaq
Midday Stock Roundup: Staar Down 4% on Board Changes - Orange County Business Journal
AEON Biopharma Releases Updated Investor Presentation Under Reg FD - TipRanks
AEON Biopharma, Inc. Unveils Biosimilar Strategy for ABP-450 - TradingView
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - MSN
Midday Stock Roundup: loanDepot Rises on Trump Move - Orange County Business Journal
AEON Biopharma (NASDAQ:AEON) & Synaptogenix (NASDAQ:TAOX) Head to Head Analysis - Defense World
Why AEON Biopharma Inc. Class stock stays on buy listsJuly 2025 Trends & Low Drawdown Investment Ideas - Улправда
Will AEON Biopharma Inc. Class stock outperform foreign stocksWeekly Stock Report & Low Drawdown Trading Strategies - Улправда
What technical signals suggest for AEON Biopharma Inc. stockGDP Growth & Momentum Based Trading Ideas - Улправда
What dividend safety rating applies to AEON Biopharma Inc. Class stockWeekly Earnings Recap & Low Risk Entry Point Guides - Улправда
AEON Biopharma, Inc. Class A Common Stock (NY: AEON - FinancialContent
What insider trading reveals about AEON Biopharma Inc. stockHigh Yield Income Stocks & Ride the Wave of Market-Beating Growth - Улправда
2026 world cup star players explained: How AEON Biopharma Inc. Class stock compares with tech leaders2026 world cup usa national team third place match key players pressing system expert forecast preview - ulpravda.ru
Will AEON Biopharma Inc. Class stock benefit from infrastructure bill2026 world cup usa national team round of 32 midfield engines transition play expert forecast tactical review - Улправда
2026 world cup match report guide: How AEON Biopharma Inc. stock benefits from global expansion2026 world cup usa national team semifinals defensive leaders pressing system winner prediction preview - Улправда
Can AEON Biopharma Inc. Class stock stage a strong rebound this quarter2026 world cup usa national team qualification playmakers high defensive line odds analysis preview - Улправда
Finanzdaten der AEON Biopharma Inc.-Aktie (AEON)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.18%
0.28%
Kapitalisierung:
|
Volumen (24h):